drugset / Trial / NCT00166686

Clonidine for Neurocognitive Sequelae

NCT00166686

RandomizedCrossoverDouble-blindTreatment

Summary

The goals of the study are to determine the efficacy of clonidine in the treatment of children with neurocognitive sequelae following the therapy of long term malignancies. In addition, the study hopes to determine the long-term effect of clonidine on children's academic and psychosocial function.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified